• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌发展建模:从肿瘤微环境到临床前应用

Modeling development of breast cancer: from tumor microenvironment to preclinical applications.

作者信息

Tang Ruizhi, Liu Xi-Qiu

机构信息

Key Laboratory for Molecular Diagnosis of Hubei Province, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

出版信息

Front Pharmacol. 2024 Dec 4;15:1466017. doi: 10.3389/fphar.2024.1466017. eCollection 2024.

DOI:10.3389/fphar.2024.1466017
PMID:39697553
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11652193/
Abstract

Breast cancer is a complex disease and its progression is related not only to tumor cells but also to its microenvironment, which can not be sufficiently reflected by the traditional monolayer cell culture manner. The novel human cancer models comprising tumor microenvironment (TME), such as tumor organoids and organs-on-a-chip, has been established in recent years to help elucidate the underlying mechanisms of tumorigenesis and promote the development of cancer therapies. In this review, we first discuss the current state of breast cancer and their treatment strategies, and elucidates the complex properties of TME of breast cancer . The culture models used in breast cancer research are then summarized with insights into recent development. Finally, we also conclude by discussing the current limitations and future directions of culture models in breast cancer research for providing a preclinical reference for the precise treatment of cancer patients.

摘要

乳腺癌是一种复杂的疾病,其进展不仅与肿瘤细胞有关,还与其微环境有关,而传统的单层细胞培养方式无法充分反映这种微环境。近年来,已建立了包括肿瘤微环境(TME)的新型人类癌症模型,如肿瘤类器官和芯片上的器官,以帮助阐明肿瘤发生的潜在机制并促进癌症治疗的发展。在本综述中,我们首先讨论乳腺癌的现状及其治疗策略,并阐明乳腺癌TME的复杂特性。然后总结了乳腺癌研究中使用的培养模型,并对其最新进展进行了深入分析。最后,我们还通过讨论乳腺癌研究中培养模型的当前局限性和未来方向来得出结论,以为癌症患者的精准治疗提供临床前参考。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ff1/11652193/a4e756029ad7/fphar-15-1466017-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ff1/11652193/73cd73852b5a/fphar-15-1466017-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ff1/11652193/81516fa89de1/fphar-15-1466017-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ff1/11652193/7a908c0ca12b/fphar-15-1466017-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ff1/11652193/a4e756029ad7/fphar-15-1466017-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ff1/11652193/73cd73852b5a/fphar-15-1466017-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ff1/11652193/81516fa89de1/fphar-15-1466017-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ff1/11652193/7a908c0ca12b/fphar-15-1466017-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ff1/11652193/a4e756029ad7/fphar-15-1466017-g004.jpg

相似文献

1
Modeling development of breast cancer: from tumor microenvironment to preclinical applications.乳腺癌发展建模:从肿瘤微环境到临床前应用
Front Pharmacol. 2024 Dec 4;15:1466017. doi: 10.3389/fphar.2024.1466017. eCollection 2024.
2
Current Status of Breast Organoid Models.乳腺类器官模型的现状。
Front Bioeng Biotechnol. 2021 Nov 5;9:745943. doi: 10.3389/fbioe.2021.745943. eCollection 2021.
3
Breast cancer organoids and their applications for precision cancer immunotherapy.乳腺癌类器官及其在精准癌症免疫治疗中的应用。
World J Surg Oncol. 2023 Oct 26;21(1):343. doi: 10.1186/s12957-023-03231-2.
4
Breast tumor-on-chip models: From disease modeling to personalized drug screening.乳腺肿瘤芯片模型:从疾病建模到个性化药物筛选。
J Control Release. 2021 Mar 10;331:103-120. doi: 10.1016/j.jconrel.2020.12.057. Epub 2021 Jan 6.
5
Breast cancer models: Engineering the tumor microenvironment.乳腺癌模型:工程化肿瘤微环境。
Acta Biomater. 2020 Apr 1;106:1-21. doi: 10.1016/j.actbio.2020.02.006. Epub 2020 Feb 9.
6
Patient-derived tumor organoids for cancer immunotherapy: culture techniques and clinical application.用于癌症免疫治疗的患者来源肿瘤类器官:培养技术与临床应用
Invest New Drugs. 2025 Apr;43(2):394-404. doi: 10.1007/s10637-025-01523-w. Epub 2025 Apr 15.
7
Mimicking tumor microenvironment by 3D bioprinting: 3D cancer modeling.通过 3D 生物打印模拟肿瘤微环境:3D 癌症建模。
Biofabrication. 2022 May 31;14(3). doi: 10.1088/1758-5090/ac6d11.
8
Breast tumor-on-chip: from the tumor microenvironment to medical applications.乳腺肿瘤芯片:从肿瘤微环境到医学应用。
Analyst. 2023 Nov 20;148(23):5822-5842. doi: 10.1039/d3an01295f.
9
Preclinical tumor organoid models in personalized cancer therapy: Not everyone fits the mold.临床前肿瘤类器官模型在个体化癌症治疗中的应用:并非每个人都适用。
Exp Cell Res. 2021 Nov 15;408(2):112858. doi: 10.1016/j.yexcr.2021.112858. Epub 2021 Sep 30.
10
Tumor organoids: synergistic applications, current challenges, and future prospects in cancer therapy.肿瘤类器官:在癌症治疗中的协同应用、当前挑战与未来前景。
Cancer Commun (Lond). 2021 Dec;41(12):1331-1353. doi: 10.1002/cac2.12224. Epub 2021 Oct 29.

本文引用的文献

1
Cancer-associated fibroblasts mediate resistance to anti-EGFR therapies in cancer.癌症相关成纤维细胞介导了癌症对抗 EGFR 治疗的耐药性。
Pharmacol Res. 2024 Aug;206:107304. doi: 10.1016/j.phrs.2024.107304. Epub 2024 Jul 11.
2
The importance of 3D fibre architecture in cancer and implications for biomaterial model design.三维纤维结构在癌症中的重要性及其对生物材料模型设计的影响。
Nat Rev Cancer. 2024 Jul;24(7):461-479. doi: 10.1038/s41568-024-00704-8. Epub 2024 Jun 17.
3
Cell-intrinsic and microenvironmental determinants of metastatic colonization.
肿瘤转移定植的细胞内和微环境决定因素。
Nat Cell Biol. 2024 May;26(5):687-697. doi: 10.1038/s41556-024-01409-8. Epub 2024 May 7.
4
Tumor-infiltrating lymphocytes in HER2-positive breast cancer treated with neoadjuvant chemotherapy and dual HER2-blockade.新辅助化疗联合双重HER2阻断治疗的HER2阳性乳腺癌中的肿瘤浸润淋巴细胞
NPJ Breast Cancer. 2024 Apr 18;10(1):29. doi: 10.1038/s41523-024-00636-4.
5
Neoadjuvant-adjuvant pertuzumab in HER2-positive early breast cancer: final analysis of the randomized phase III PEONY trial.曲妥珠单抗新辅助-辅助治疗 HER2 阳性早期乳腺癌:PEONY 随机 III 期试验的最终分析。
Nat Commun. 2024 Mar 9;15(1):2153. doi: 10.1038/s41467-024-45591-7.
6
Promises and challenges of organoids: From humanized to human derived.类器官的前景与挑战:从人源化到人类来源。
Cell Stem Cell. 2024 Mar 7;31(3):281-282. doi: 10.1016/j.stem.2024.02.002.
7
Fabrication of a Coculture Organoid Model in the Biomimetic Matrix of Alginate to Investigate Breast Cancer Progression in a TAMs-Leading Immune Microenvironment.利用海藻酸钠仿生基质构建共培养类器官模型以研究 TAMs 主导的免疫微环境中乳腺癌的进展。
ACS Appl Mater Interfaces. 2024 Mar 6;16(9):11275-11288. doi: 10.1021/acsami.3c17863. Epub 2024 Feb 21.
8
Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance.靶向M2样肿瘤相关巨噬细胞是克服抗肿瘤耐药性的一种潜在治疗方法。
NPJ Precis Oncol. 2024 Feb 10;8(1):31. doi: 10.1038/s41698-024-00522-z.
9
The Multifunction Role of Tumor-Associated Mesenchymal Stem Cells and Their Interaction with Immune Cells in Breast Cancer.肿瘤相关间充质干细胞的多功能作用及其与乳腺癌免疫细胞的相互作用。
Immunol Invest. 2023 Nov;52(7):856-878. doi: 10.1080/08820139.2023.2249025. Epub 2023 Aug 24.
10
Roles of macrophages in tumor development: a spatiotemporal perspective.巨噬细胞在肿瘤发展中的作用:时空视角。
Cell Mol Immunol. 2023 Sep;20(9):983-992. doi: 10.1038/s41423-023-01061-6. Epub 2023 Jul 10.